Sheila Weinmann, PhD, MPH, is an epidemiologist whose research focuses on cancer etiology, screening, and progression, with an emphasis on molecular epidemiology. Her interests also include pharmacoepidemiology and infectious disease epidemiology.
Dr. Weinmann has more than 25 years’ experience leading cohort and case-control epidemiologic studies at the Center for Health Research and at the University of Washington. She has been the principal investigator on epidemiologic studies of molecular factors in relation to breast cancer recurrence, prostate cancer screening efficacy, molecular and other factors in relation to prostate cancer mortality after prostatectomy, statin use in relation to prostate cancer recurrence, renal cell cancer risk factors, the molecular biology of renal cell cancer progression, and pregnancy outcomes after surgical treatment for cervical dysplasia.
She has also conducted research on cervical, bladder, and colorectal cancers, varicella, herpes zoster, human papillomavirus (HPV), invasive pneumococcal disease, pertussis, chronic obstructive pulmonary disease, and primary cardiac arrest.
Currently, Dr. Weinmann is the co-principal investigator of a project studying treatment for metastatic breast cancer. She also serves on the Leadership Team for the national Kaiser Permanente Research Bank, which ultimately will include the electronic health record information, biospecimen material, and health questionnaire data of over 400,000 consenting KP members. The goal of this biobank is to build a world-class resource to contribute to breakthroughs in medical knowledge.
Dr. Weinmann received her PhD in epidemiology from the University of Washington. She is a clinical assistant professor in the Department of Public Health and Preventive Medicine of Oregon Health & Science University. She is former executive director of the Northwest Portland Area Indian Health Board and has worked on several studies of health problems among American Indians and Alaska Natives.
Selected Publications
- Weinmann S, Francisco MC, Kwan ML, Bowles EJA, Rahm AK, Greenlee RT, Stout NK, Pole JD, Kushi LH, Smith-Bindman R, Miglioretti DL. Positive predictive value and sensitivity of ICD-9-CM codes for identifying pediatric leukemia. Pediatr Blood Cancer 2022 Feb;69(2):e29383. doi: 10.1002/pbc/29383/ PMID: 34773439
- Rohan TE, Arthur R, Wang Y, Weinmann S, Ginsberg M, Loi S, Salgado R. Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer. Breast Cancer Res 2021 Jan 30;23(1):15. doi: 10.1186/s13058-021-01395-x. PMID: 33516237
- Jindal S, Pennock ND, Sun D, Horton W, Ozaki MK, Narasimhan J, Bartlett AQ, Weinmann S, Goss PE, Borges VF, Xia Z, Schedin P. Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes. Nat Commun 2021 Nov 3;12(1):6341. doi: 10.1038/s41467-021-26505-3. PMID: 34732713
- Weinmann S, Leo MC, Francisco M, Jenkins CL, Barry T, Leesman G, Linke SP, Whitworth PW, Patel R, Pelicane J, Warnberg F, Bremer T. Validation of a ductal carcinoma in situ biomarker profile for risk of recurrence after breast-conserving surgery with and without radiotherapy. Clin Cancer Res. 2020 Aug 1;26(15):405404063. doi:10.1158/1078-0432.CCR-19-1152. PMID: 32341032
- Weinmann S, Irving SA, Koppulu P, Naleway AL, Belongia EA, Hambridge SJ, Jackson ML, Klein NP, Lewin B, Liles E, Marin M, Smith N, Weintraub E, Chun C. Incidence of herpes zoster among varicella-vaccinated children, by number of vaccine doses and simultaneous administration of measles, mumps, and rubella vaccine. Vaccine 2020 Aug;38(37):5880-5884. doi: 10.1016/j.vaccine.2020.05.006. PMID:3244193
- Weinmann S, Naleway A, Swamy G, Krishnarajah G, Arondekar B, Fernandez J, Myers E. PLoS One. Pregnancy outcomes after treatment for cervical cancer precursor lesions: An observational study. 2017 Jan 4;12(1):e0165276. doi: 10.1371/journal.pone.0165276. eCollection 2017. Erratum in: PLoS One. 2017 Feb 13;12 (2):e0172417. PMID: 28052083 [PubMed - indexed for MEDLINE]
- Weinmann S, Williams AE, Kamineni A, Buist DS, Masterson EE, Stout NK, Start A, Ross TR, Owens CL, Field TS, Doubeni CA. Cervical cancer screening and follow-up in 4 geographically diverse US health care systems, 1998 through 2007. Cancer 2015 Sep 1;121(17):2976-83.
- Weinmann S, Van Den Eeden SK, Haque R, Chen C, Richert-Boe K, Schwartzman J, Gao L, Berry DL, Kallakury BV, Alumkal JJ. Immunohistochemical expression of ERG in the molecular epidemiology of fatal prostate cancer study. Prostate 2013; 73(13):1371-7. PMCID: PMC3745520
- Weinmann S, Vollmer WM, Breen V, Heumann M, Hnizdo E, Villnave J, Doney B, Graziani M, McBurnie MA, Buist AS. COPD and occupational exposures: a case-control study. J Occup Environ Med 2008 May;50(5):561-569.
- Weinmann S, Richert-Boe KE, Van Den Eeden SK, Enger SM, Rybicki BA, Shapiro JA, Weiss NS. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study. Epidemiology 2005 May; 16(3):367-76. PMID: 15824554